Assessment of pharmacokinetic parameters, oral bioavailability, and physiological effects of amantadine in horses
Hannah L Riley, Khursheed R Mama, Megan E Jacobs, Daniel S McKemie, Philip H Kass, Heather K Knych · 2026
Read Assessment of pharmacokinetic parameters, oral bioavailability, and physiological effects of amantadine in horses by Hannah L Riley, Khursheed R Mama, Megan E Jacobs, Daniel S McKemie, Philip H Kass, Heather K Knych (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13520257.txt.
Description
Hannah L Riley leads a six-author pharmacology study in 2026 measuring how amantadine behaves in horses, a first step toward using it against hard-to-treat chronic pain. The drug blocks NMDA receptors involved in pain amplification, yet equine dosing data were missing. Eight horses received one intravenous dose and three oral doses in a randomized crossover schedule, with blood sampled for up to 96 hours.
Peak blood levels rose with dose size, and the drug cleared with a half-life near four hours. Only about 23 percent of an oral dose reached the circulation. Five horses showed brief wobbliness after the intravenous dose, with no other major effects. Riley and colleagues judge the drug well tolerated and ready for pain-effect trials.
Catalog record
| CREATOR | Hannah L Riley, Khursheed R Mama, Megan E Jacobs, Daniel S McKemie, Philip H Kass, Heather K Knych |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 41451 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |